A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer

✍ Scribed by R. Charles Coombes, Fatima Cardoso, Nicolas Isambert, Thierry Lesimple, Patrick Soulié, Concepcion Peraire, Veronique Fohanno, Anne Kornowski, Tauhid Ali, Peter Schmid…show all 10hide

• Book ID: 120964855
• Publisher: Springer US
• Year: 2013
• Tongue: English
• Weight: 406 KB
• Volume: 140
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-013-2597-8